These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15796147)

  • 1. Determination of high and low molecular weight molecules of icodextrin in plasma and dialysate, using gel filtration chromatography, in peritoneal dialysis patients.
    García-López E; Anderstam B; Heimbürger O; Amici G; Werynski A; Lindholm B
    Perit Dial Int; 2005; 25(2):181-91. PubMed ID: 15796147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis.
    García-López E; Pawlaczyk K; Anderstam B; Qureshi AR; Kuzlan-Pawlaczyk M; Heimbürger O; Werynski A; Lindholm B
    Perit Dial Int; 2007; 27(4):415-23. PubMed ID: 17602150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Icodextrin degradation products in spent dialysate of CAPD patients and the rat, and its relation with dialysate osmolality.
    de Waart DR; Zweers MM; Struijk DG; Krediet RT
    Perit Dial Int; 2001; 21(3):269-74. PubMed ID: 11475342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Peritoneal Dialysis Dwells With Icodextrin: Kinetics of Transperitoneal Fluid and Polyglucose Transport.
    Olszowska A; Waniewski J; Stachowska-Pietka J; Garcia-Lopez E; Lindholm B; Wańkowicz Z
    Front Physiol; 2019; 10():1326. PubMed ID: 31736769
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of icodextrin in peritoneal dialysis patients.
    Moberly JB; Mujais S; Gehr T; Hamburger R; Sprague S; Kucharski A; Reynolds R; Ogrinc F; Martis L; Wolfson M
    Kidney Int Suppl; 2002 Oct; (81):S23-33. PubMed ID: 12230479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of alpha-amylase activity in serum and dialysate from patients using icodextrin-based peritoneal dialysis fluid.
    Anderstam B; García-López E; Heimbürger O; Lindholm B
    Perit Dial Int; 2003; 23(2):146-50. PubMed ID: 12713081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal kinetics and mesothelial markers in CCPD using icodextrin for daytime dwell for two years.
    Posthuma N; Verbrugh HA; Donker AJ; van Dorp W; Dekker HA; Peers EM; Oe PL; ter Wee PM
    Perit Dial Int; 2000; 20(2):174-80. PubMed ID: 10809240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between ultrafiltrate volume with icodextrin and peritoneal transport pattern according to the peritoneal equilibration test.
    Araújo Teixeira MR; Pecoits-Filho RF; Romão Junior JE; Sabbaga E; Marcondes MM; Abensur H
    Perit Dial Int; 2002; 22(2):229-33. PubMed ID: 11990408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients.
    Paniagua R; Ventura MD; Avila-Díaz M; Cisneros A; Vicenté-Martínez M; Furlong MD; García-González Z; Villanueva D; Orihuela O; Prado-Uribe MD; Alcántara G; Amato D
    Perit Dial Int; 2009; 29(4):422-32. PubMed ID: 19602608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid assay for icodextrin determination in plasma and dialysate.
    Wang R; Moberly JB; Martis L; Shockley TR; Mongoven JW; Patel H; Kunzler J; Hughes G; Gass J
    Adv Perit Dial; 2002; 18():91-5. PubMed ID: 12402596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate of synthetic oligosaccharide degradation as a novel measure of amylase activity in peritoneal dialysis patients.
    García-López E; Werynski A; Heimbürger O; Filho JC; Lindholm B; Anderstam B
    Perit Dial Int; 2008; 28(3):296-304. PubMed ID: 18474923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling of icodextrin hydrolysis and kinetics during peritoneal dialysis.
    Stachowska-Pietka J; Waniewski J; Olszowska A; Garcia-Lopez E; Wankowicz Z; Lindholm B
    Sci Rep; 2023 Apr; 13(1):6526. PubMed ID: 37085652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the Peritoneal Absorption of Icodextrin in Rats and Humans Including the Effect of α-Amylase Activity in Dialysate.
    Akonur A; Holmes CJ; Leypoldt JK
    Perit Dial Int; 2015; 35(3):288-96. PubMed ID: 24584610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Biocompatibility of Neutral Icodextrin Peritoneal Dialysis Fluid.
    Shimada S; Mori T; Koizumi K; Sato S; Oba-Yabana I; Ohsaki Y; Sato E; Naganuma E; Kurasawa N; Tsuchikawa M; Ito S
    Adv Perit Dial; 2016; 32():46-50. PubMed ID: 28988589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of a continuous ambulatory peritoneal dialysis (CAPD) technique with one icodextrin-containing and two biocompatible glucose-containing dialysates for preservation of residual renal function and biocompatibility in incident CAPD patients.
    Yoon HE; Chang YK; Shin SJ; Choi BS; Kim BS; Park CW; Song HC; Yoon SA; Jin DC; Kim YS
    J Korean Med Sci; 2014 Sep; 29(9):1217-25. PubMed ID: 25246739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
    Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
    Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Icodextrin improve angiogenesis of peritoneal membrane in continuous ambulatory peritoneal dialysis patients].
    Dai HL; Lin AW; Qian JQ; Fang W; Ni ZH; Cao LO; Lin XH; Wu QW
    Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(40):2843-7. PubMed ID: 21162796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD.
    Rippe B; Levin L
    Kidney Int; 2000 Jun; 57(6):2546-56. PubMed ID: 10844624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
    Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
    Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid.
    Lin A; Qian J; Li X; Yu X; Liu W; Sun Y; Chen N; Mei C;
    Clin J Am Soc Nephrol; 2009 Nov; 4(11):1799-804. PubMed ID: 19808224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.